I spoke with an MS patient on copaxone and she is not going to be easy to persuade to try any other Med for the condition. I think there will be a strong entrenchment and not wholesale switching, at least not until more years of experience on the orals.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.